Follow
Joel Sng
Joel Sng
SingHealth Duke-NUS Institute of PRecISion Medicine (PRISM)
Verified email at singhealth.com.sg
Title
Cited by
Cited by
Year
AIRE expression controls the peripheral selection of autoreactive B cells
J Sng, B Ayoglu, JW Chen, JN Schickel, EMN Ferre, S Glauzy, ...
Science immunology 4 (34), eaav6778, 2019
772019
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production
E Cotzomi, P Stathopoulos, CS Lee, AM Ritchie, JN Soltys, FR Delmotte, ...
Brain 142 (6), 1598-1615, 2019
722019
Emerging stem cell therapies: treatment, safety, and biology
J Sng, T Lufkin
Stem Cells International 2012, 2012
572012
Antigen-mediated regulation in monoclonal gammopathies and myeloma
S Nair, J Sng, CS Boddupalli, A Seckinger, M Chesi, M Fulciniti, L Zhang, ...
JCI insight 3 (8), 2018
502018
Brief report: defective early B cell tolerance checkpoints in Sjögren's syndrome patients
S Glauzy, J Sng, JM Bannock, JE Gottenberg, AS Korganow, P Cacoub, ...
Arthritis & Rheumatology 69 (11), 2203-2208, 2017
452017
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
M Thura, AQ Al-Aidaroos, A Gupta, CE Chee, SC Lee, KM Hui, J Li, ...
Nature communications 10 (1), 2484, 2019
372019
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs
M Thura, JXE Sng, KH Ang, J Li, A Gupta, JM Hong, CW Hong, Q Zeng
Bioscience reports 41 (9), BSR20211491, 2021
342021
In vivo genome-wide analysis of multiple tissues identifies gene regulatory networks, novel functions and downstream regulatory genes for Bapx1 and its co-regulation with …
S Chatterjee, V Sivakamasundari, SP Yap, P Kraus, V Kumar, X Xing, ...
BMC genomics 15, 1-18, 2014
192014
Positive and negative selection shape the human naive B cell repertoire
JW Chen, JN Schickel, N Tsakiris, J Sng, F Arbogast, D Bouis, D Parisi, ...
The Journal of clinical investigation 132 (2), 2022
152022
Filling the silent void: genetic therapies for hearing impairment
J Sng, T Lufkin
Genetics research international 2012, 2012
72012
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
M Thura, AQ Al-Aidaroos, A Gupta, CE Chee, SC Lee, KM Hui, J Li, ...
Nature Communications 12, 2021
12021
Advances in Stem Cell Therapies
T Lufkin, J Sng
Pluripotent Stem Cells, 2013
12013
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)
M Thura, AQ Al-Aidaroos, A Gupta, CE Chee, SC Lee, KM Hui, J Li, ...
NATURE PORTFOLIO, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–13